Thalidomide Embryopathy

Overview

What is thalidomide embryopathy?

Thalidomide embryopathy is a collection of abnormalities that result in an infant that has been exposed to the drug thalidomide in utero, or during pregnancy, at critical times of development. The most recognizable effects of thalidomide embryopathy are limb reduction defects, including complete absence of limbs. Other abnormalities including cardiac, or heart, defects, gastrointestinal defects, and abnormalities of the external ear are also commonly associated with thalidomide embryopathy.

SOURCE: Emory University - Department of Human Genetics in collaboration with ThinkGenetic • https://www.thinkgenetic.com/diseases/thalidomide-embryopathy/overview/7259 • DATE UPDATED: 2016-06-16

References

This content comes from a hidden element on this page.

The inline option preserves bound JavaScript events and changes, and it puts the content back where it came from when it is closed.

Remember Me